Montelukast in Children With Wheezing

Summary

In this study children with recurrent wheezing (\>/= 2 episodes in the last 6 months)and aged less than 2 years will be enrolled as outpatients. They will undergo lung function evaluation by Rint and by assessment of the flow curves at baseline and after 4 weeks of treatment with Montelukast 4 mg/day. Symptom dairies will be filled by parents during the study period.

Timeline

Start

2009-09

Primary completion

2013-12

Completion

2014-12

Drugs

Indications